1Calvino MC, Llorca J, Garcia Porrua C, et al. Henoch- Schonlein purpura in children from northwestern Spain: a 20 year epidemiologic and clinical study[J]. Medicine,2001, 80(5)279-290.
2Rostoker G. Henoch-Schonlein purpura in children and adults:diagnosis, pathophysiology and management[J]. Biol Drugs ,2001,15(2) :99-138.
3Wiercinski R, Zoch-Zwierz W, ,Wasilewtka A,et al. Lymphocyte subpopulations of peripheral blood in children with Sehonlein-Henoch purpura and IgA nephropathy[J].Pol Merkuriusz Lek, 2001,10(58) :244-246.
4Cabellos C, Macintyre DE, Forrest M, et al. Differing roles for platelet-activating factor during TNFlammation of the lung and subarachnoid space[J].J Clin Invest, 1992,90(2)612-618.
5Ha TS. The role of tumornecrosis factor-alpha in Henoch- Schonleinpurpura[J]. Pediatr Nepkrol, 2005,20 (2) : 149- 153.
6Shin JI, Kim JH, Lee JS. The diagnostic value of IgA deposition inHe-noch-Sch nlein purpura[J]. Pediatr Dermatol,2008, 25(1): 140-141.
7Mills JA,Michel BA, Bloch DA,et al. The American College of heumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum, 1990,33(8) : 1114-1121.
8Kaku Y, Nohara K, Honda S, et al. Renal involvement in Henoch-Schonlein purpura:a multivariate analysis of prognostic factors.Kidney Int, 1998,53(6) : 1755-1759.
9Wiercinski R, Zoch-Zwierz W, Wasilewska A, et al. Lymphocyte subpopulations of peripheral blood in children with Schonlein-Henoch purpura and IgA nephropathy. Pol Merkuriusz Lek,2001,10(58) :244-246.
10Allen AC, Willis FR, Beatie J, et al. Abonrmal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis.Nephrol Dial Transpl, 1998,13(4) :930-934.
